期刊文献+

胰蛋白酶复合黏弹剂对后发性白内障的预防作用 被引量:1

Prevention of posterior capsule opacification by trypsin-VISCOAT mixture
下载PDF
导出
摘要 目的探讨胰蛋白酶复合黏弹剂预防后发性白内障(PCO)的有效性及安全性。方法将25只新西兰白兔50只眼平均分为5组,每组10只眼。所有实验眼均行白内障超声乳化手术,在晶状体囊袋内分别注入普通黏弹剂、质量分数0.5%胰蛋白酶复合黏弹剂+血清复合黏弹剂、0.75%胰蛋白酶复合黏弹剂+血清复合黏弹剂、1%胰蛋白酶复合黏弹剂+血清复合黏弹剂或1%胰蛋白酶复合黏弹剂并在囊袋内保留3min。摘除实验眼并制备常规固定切片,行苏木精-伊红染色,光镜下观察各组兔晶状体上皮细胞(LECs)和角膜内皮细胞(CECs)的形态学变化。结果 LECs计数随着胰蛋白酶剂量的增加而逐渐减少,4个实验组LECs计数的差异有统计学意义(H=36.696,P=0.00)。1%胰蛋白酶复合黏弹剂+血清复合黏弹剂组的CECs计数为(34.0±2.6)个,而1%胰蛋白酶复合黏弹剂组为(27.0±4.7)个,2组差异有统计学意义(Z=-3.792,P=0.00)。组织学检查表明,光学显微镜下普通黏弹剂组LECs结构和排列正常;0.5%胰蛋白酶复合黏弹剂+血清复合黏弹剂组和0.75%胰蛋白酶复合黏弹剂+血清复合黏弹剂组可见部分LECs脱落,眼内其他组织形态无明显异常;1%胰蛋白酶复合黏弹剂+血清复合黏弹剂组LECs完全脱落,但CECs及眼内其他组织形态无明显异常;1%胰蛋白酶复合黏弹剂组LECs完全脱落,伴有CECs的小片状脱落。结论白内障术中运用1%胰蛋白酶复合黏弹剂配合血清复合黏弹剂能安全有效地去除LECs,为PCO的预防提供了一个新的治疗途径。 Background The intracapsular injection of lens of some drugs to prevent the posterior capsule opacification (PCO) is a new studying field.The lens intracapsular injection with the combination of trypsin,serum with VISCOAT during the phacoficication is concerned.Objective This study was to assess the ability of delivering trypsin-VISCOAT mixture directly into lens epithelial cells (LECs) in vitro and evaluate the effectiveness and safety of trypsin-VISCOAT mixture.Methods Fifty eyes from 25 clean New Zealand white rabbits were divided into 5 groups at average.Phacoaspiration of lens was performed in all the experimental rabbits,and regular VISCOAT,1% trypsin+serum+VISCOAT,0.75% trypsin+serum+VISCOAT,0.5% trypsin+serum+VISCOAT or 1% trypsin+VISCOAT were injected into the capsular bag of lens respectively for 3 minutes and then were removed during the operation.Animal eyeballs were enucleated in 24 hours after operation and the samples of lens capsular membrane were prepared for the morphological examination under the optical microscope.Results The counts of LECs was gradually decreased with the increase of trypsin concentration (H=36.696,P=0.00).The corneal endothelial cells counts in 1% trypsin+serum+VISCOAT group were 34.0±2.6 cells/field,and that in 1% trypsin+VISCOAT group was 27.0±4.7 cells/field,showing a statistically significant difference (Z=-3.792,P=0.00).Histological examination of capsular bag revealed the normal LECs in regular VISCOAT group.However,partical lose of LECs were seen in 0.5% trypsin+serum+VISCOAT group and 0.75% trypsin+serum+VISCOAT group,and the destruction of LECs was found in 1% trypsin+serum+VISCOAT group,but the corneal endothelial cells,iris and anterior chamber angle showed the normal structure under the optical microscope.In 1% trypsin+VISCOAT group,the destruction of LECs and corneal endothelial cells could be seen.Conclusion The mixture of 1% trypsin and VISCOAT with serum and VISCOAT allows selective delivery of toxic agents directly into the capsular bag to remove the residual LECs after phacoaspiration.The intracapsular injection of mixture of 1% trypsin and VISCOAT with serum and VISCOAT is a new approach to the prevention of PCO.
作者 陆琳娜 李俊
出处 《眼科研究》 CSCD 北大核心 2010年第10期941-945,共5页 Chinese Ophthalmic Research
关键词 胰蛋白酶 晶状体上皮细胞 后发性白内障 trpsin lens epithelial cells posterior capsule opacification
  • 相关文献

参考文献16

  • 1Jose RMJ,Bender LE,Boyce JF,et al.Correlation between the measurement of posterior capsule opacification severity and visual function testing[J].J Cataract Refract Surg,2005,31(3):534-542.
  • 2周激波,管怀进,顾海雁.农村短期集中白内障防盲手术后患者视功能和生存质量的调查[J].眼科研究,2006,24(3):320-323. 被引量:13
  • 3Buehl W,Sacu S,Findl O.Association between intensity of posterior capsule opacification and contrast sensitivity[J].Am J Ophthalmol,2005,140(5):927-930.
  • 4Congdon NG,Ruiz S,Suzuki M,et al.Determinants of pediatric cataract program outcomes and follow-up in a large series in Mexico[J].J Cataract Refract Surg,2007,33(10):1775-1780.
  • 5Hamada Y,Okada TS.The differentiating ability of rat lens epithelial cells in culture[J].Dev Growth Diff,1977,19(1/3):265-273.
  • 6Vasavada AR,Dholakia SA,Raj SM,et al.Effect of cortical cleaving hydrodissection on posterior capsule opacification in age-related nuclear cataract[J].J Cataract Refract Surg,2006,32(7):1196-1200.
  • 7Pollhammer M,Meiller R,Rummelt C,et al.In situ ablation of lens epithelial cells in porcine eyes with the laser photolysis system[J].J Cataract Refract Surg,2007,33(4):697-701.
  • 8Malecaze F,Decha A,Serre B,et al.Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells[J].Gene Ther,2006,13(5):440-448.
  • 9Awasthi N,Wang-Su ST,Wagner BJ.Downregulation of MMP-2 and-9 by proteasome inhibition:a possible mechanism to decrease LEC migration and prevent posterior capsular opacification[J].Invest Ophthalmol Vis Sci,2008,49(5):1998-2003.
  • 10Abdelwahab MT,Kugelberg M,Seregard S,et al.Safety of irrigation with 5-fluorouracil in a sealed-capsule irrigation device in the rabbit eye[J].J Cataract Refract Surg,2007,33(9):1619-1623.

二级参考文献13

  • 1周激波,管怀进,顾海雁.白内障患者防盲手术前视力状况和生存质量的调查[J].中国眼耳鼻喉科杂志,2005,5(6):379-381. 被引量:3
  • 2Duncan G,Nat Med,1997年,3卷,9期,1026页
  • 3Pokharel GP,Regmi G,Shrestha SK,et al.Prevalence of blindness and cataract surgery in Nepal[J].Br J Ophthalmol,1998,82:600-605.
  • 4Fletcher AE,Ellwein LB,Selvaraj S,et al.Measurements of vision function and quality of life in patients with cataracts in southern India.Report of instrument development[J].Arch Ophthalmol,1997,115:767-774.
  • 5Fletcher AE,Ellwein LB,Selvaraj S,et al.The Madurai intraocular lens study Ⅲ:visual functioning and quality of life[J].Am J Ophthalmol,1998,125:26-35.
  • 6Pokharel GP,Selvaraj S,Ellwein LB.Visual functioning and quality of outcomes among cataract operated and unoperated blind populations in Nepal[J].Br J Ophthalmol,1998,82:606-610.
  • 7Zhao J,Rui R,Jia L,et al.Visual acuity and quality of life outcomes in cataract patients in Shunyi county,China[J].Am J Ophthalmol,1998,126:515-523.
  • 8He M,Xu J,Li S,et al.Visual acuity and quality of life in patients with cataract in Doumen County,China[J].Ophthalmology,1999,106:1609 -1615.
  • 9Lau J,Michon JJ,Chan WS,et al.Visual acuity and quality of life outcomes in cataract surgery patients in Hong Kong[J].Br J Ophthalmol,2002,86:12-17.
  • 10吴明星,利华明,李绍珍.柔毛霉素、骆驼蓬总碱防治兔后发性白内障的实验研究[J].中国实用眼科杂志,1999,17(4):204-207. 被引量:9

共引文献18

同被引文献30

  • 1张俊鸽,李平华.后发性白内障预防的研究进展[J].眼科新进展,2007,27(1):69-71. 被引量:5
  • 2王迪男,梁皓.后发性白内障的防治进展[J].右江民族医学院学报,2007,29(3):453-455. 被引量:1
  • 3李桂荣,苏冠方,周鸿雁.老年白内障晶状体上皮细胞凋亡及凋亡基因的表达[J].中国老年学杂志,2007,27(12):1186-1188. 被引量:8
  • 4姬红培,吴明星,张唯伟.后发性白内障的研究进展[J].眼科新进展,2007,27(8):635-638. 被引量:18
  • 5龚非力.医学免疫学[M].2版.北京:科学出版社,2006:256-258.
  • 6Schaurnberg DA, Dana MR, Christen WG, ct al. A systematric overview of the incidence of posterior opacificaion [J]. Ophthalmology, 1998, 105(7): 1213-1221.
  • 7Ishiboshi T. collagen types inhuman posterior capsule opacification [J]. Cataract Refract Surg, 1994, 21(8): 643-648.
  • 8David J. Prevention of posterior capsule opacifiaation by drugs [J]. Cell phyaiol, 1992, 153(12): 483-485.
  • 9Neumayer T, Findl O, Buehl W, et al. Long term changes in the morphology of posterior capsul opacification [J]. J Cataract Refract Surg, 2005, 30(11): 2120-2128.
  • 10Malecaze F, Deeha A, Serre B, et al. Prevention of posterior capsule opaeifieation by the induction of therapeutic apoptosis of residual lens cells [J]. Gene Ther, 2006, 13(5): 440-448.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部